News

Avadel Pharmaceuticals Unveils Promising LUMRYZ Data at World Sleep

Avadel Pharmaceuticals Unveils Promising LUMRYZ Data at World Sleep

Avadel Pharmaceuticals Presents LUMRYZ Findings at World Sleep Conference

At the prestigious World Sleep 2025 conference, Avadel Pharmaceuticals plc, a company focused on innovative medicine, is excited to share groundbreaking findings regarding LUMRYZ™, its once-nightly sodium oxybate treatment for narcolepsy. This year, the conference is set to showcase a wealth of research, including one oral presentation and 16 poster presentations around the efficacy of LUMRYZ.

New Insights from the REFRESH Study

Understanding the Impact of Once-Nightly Dosing

New data from the REFRESH study highlights the significant advantages of a once-nightly dosing regimen over traditional twice-nightly options. As described by Dr. Gerard J. Meskill, the CEO of Tricoastal Narcolepsy and Sleep Disorders Center, having a single bedtime dose means patients do not have the anxiety of missing a dose in the night, leading to better medication adherence and overall reduced burdens for both the patients and their partners.

Exploring Benefits for Narcolepsy Patients

Results from Clinical Highlights

Highlights from the World Sleep event illustrate that participants who switched to LUMRYZ or were new to treatment experienced clinically relevant improvements. For the 51 patients involved in the REFRESH study, key metrics indicating efficacy, like the Epworth Sleepiness Scale scores, saw significant improvements—demonstrating a move towards normal ranges of sleepiness. The study also noted a reduction of symptoms on the Narcolepsy Severity Scale and the Sheehan Disability Scale, suggesting an overall enhancement in patients' daily functioning.

Data on Comorbidities in Narcolepsy Patients

Understanding Related Health Conditions

In addition to immediate treatment outcomes, Avadel’s presentations will include intriguing analyses on the comorbidities associated with narcolepsy. A study involved 1,659 narcolepsy patients compared with matched controls, pointing out that sleep disorders, mental health issues, and chronic pain conditions occur more frequently in narcolepsy patients. Awareness of these comorbidities is critical as it helps in understanding the full impact of narcolepsy on overall health and enhances treatment planning.

Future Directions for LUMRYZ and Narcolepsy Treatment

The Road Ahead

Avadel continues to position LUMRYZ as a transformative option for patients grappling with narcolepsy, emphasizing the promising avenues identified through its real-world studies. As more data is gathered and analyzed, the hope is to firmly establish LUMRYZ as the go-to treatment option that comprehensively addresses narcolepsy symptoms and improves patients' quality of life.

About LUMRYZ™

LUMRYZ is a novel extended-release treatment approved for cataplexy and excessive daytime sleepiness in patients aged seven and older. Launching in 2023, this medication has been underpinned by successful results from pivotal trials, demonstrating significant improvements compared to placebo. The FDA granted it orphan drug exclusivity based on its unique once-nightly dosing, addressing a critical gap in narcolepsy management.

Contact Information

If you're interested in more information, please contact Avadel's investor relations at Austin Murtagh at Austin.Murtagh@precisionAQ.com or call (212) 698-8696.

Frequently Asked Questions

What is LUMRYZ used for?

LUMRYZ is used to treat cataplexy and excessive daytime sleepiness in patients with narcolepsy aged seven years and older.

When was LUMRYZ approved?

LUMRYZ was approved by the FDA in May 2023.

What are the primary outcomes of the REFRESH study?

The REFRESH study demonstrated clinical improvements in excessive daytime sleepiness and narcolepsy symptoms in participants switching to LUMRYZ.

What were the findings regarding comorbidities in narcolepsy patients?

Higher rates of sleep, pain, and psychiatric disorders were observed in narcolepsy patients compared to controls.

Where can I find more information on LUMRYZ?

More detailed information can be found on the Avadel Pharmaceuticals website or by contacting their investor relations.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Disney Springs Hotel Rates Test Holiday Demand Depth

Updated Category News Views 161

A $145 room rate is the sort of holiday bait that gets my attention before the fake snow does. Disney Springs Resort Area Hotels are extending a seasonal offer for stays through Dec. 18, 2026, with bookings open only through Nov. 20. That is a very narrow selling window, and it tells you plenty: these seven independent hotels want to fill rooms during a lucrative but...

Continue Reading
Discount Tire’s $10 Correction Matters This Black Friday

Updated Category News Views 95

A ten-dollar correction is not a catastrophe, but it is precisely the sort of loose screw that deserves a glance before Black Friday shouting gets underway. Discount Tire says an earlier version of its Nov. 17, 2026 promotion release listed combined instant savings of $390 when the correct maximum is $380. The company issued the correction and supplied a revised release....

Continue Reading
Foresite's No. 22 Rank Signals MSSP Growth Momentum

Updated Category News Views 66

Cybersecurity rankings can be a carnival of shiny badges, but No. 22 out of 250 managed security providers is not something a serious buyer should casually brush aside. Foresite Cybersecurity landed there in MSSP Alert's 2026 survey and also made three of the program's new Prestige Top 10 lists: Best Enterprise Focused MSSP, Most Innovative MSSPs, and Fastest Growing...

Continue Reading
Aimbient's OR Timestamp Study Puts Efficiency to Test

Updated Category News Views 154

A camera catching a patient’s arrival on time may sound mundane, but operating rooms are where mundane details can turn into serious money and better operational decisions. Aimbient’s newly corrected announcement points to an independently conducted Stanford Medicine study in JAMA Surgery that tested whether its computer-vision system could document key operating-room...

Continue Reading
RBC Signals Gets $10 Million to Push Space Infrastructure

Updated Category News Views 25

Ground stations are the unglamorous plumbing of the space economy, and somebody finally put fresh capital behind the wrench. RBC Signals says it has received a $10 million strategic growth investment led by Washington Harbour Partners, aimed at enlarging its government-services operation and pushing several newer space-connectivity tools toward commercial use. This is a...

Continue Reading
DigiKey’s Arduino Webinar Puts Edge AI Hardware to Work

Updated Category News Views 87

A Small Board With a Big Practical Question Edge AI is finally getting dragged out of the slide deck and onto the workbench, which is where it ought to prove itself. DigiKey plans to host a free 60-minute webinar on Dec. 2, 2026, at 10 a.m. CST covering Arduino’s new VENTUNO Q edge AI computer. The session promises a hardware tour, an Arduino App Lab walkthrough, and a...

Continue Reading
Insta360 Tests Holiday Demand With $170 Gear Discounts

Updated Category News Views 80

A discount banner can reveal plenty about a hardware brand's priorities, and Insta360's latest Black Friday push is plainly built to put more of its ecosystem into customers' hands. The company is advertising savings of up to US$170 across cameras, gimbals, microphones, webcams, and accessories, with the promotion available for a limited time through its own store and...

Continue Reading
Emaar's Huspy Deal Brings Financing Into Home Sales

Updated Category News Views 101

Mortgage paperwork is nobody’s idea of luxury, yet it can wreck a property sale faster than a bad floor plan. Emaar Properties has partnered with Dubai-based Huspy to give its customers access to mortgage advice and financing comparisons from more than 20 UAE banks. It is not a flashy tower launch or a headline-grabbing land purchase. Frankly, that is why investors...

Continue Reading
Hitachi's Quiet Fusion Bet Is Really About Data Control

Updated Category News Views 88

Weeks of engineering work can vanish because one storage system hiccups, which is a rotten way to learn that data infrastructure belongs in the mission-critical column. Esteyco’s new environment, built with Hitachi Vantara and implemented by Quadrics Sistemas, is not a fusion breakthrough. It is the less glamorous machinery that keeps serious fusion research from...

Continue Reading
Miami Office Puts Dubai Closer to U.S. Business Deal Flow

Updated Category News Views 57

Miami is not a random pin on a map; it is a deliberate front door to the Americas, and Dubai International Chamber has decided it needs someone standing in it. The chamber opened a representative office there on November 19, 2026, its second in the United States after launching in New York during the Dubai Business Forum – USA in November 2025. This is not the sort of...

Continue Reading

Top 5 Most Recently Viewed Articles

Hampton University Museum Reopens to Enrich Cultural Heritage

Updated Category News Views 426

Hampton University Museum Reopens to Enrich Cultural Heritage In an exciting development for cultural enthusiasts, the Hampton University Museum, recognized as the nation's oldest African American museum, has reopened its doors following a comprehensive renovation. This reopening showcases a vibrant collection of exhibits and an enhanced visitor experience. Since its...

Continue Reading
Atlas Systems Recognized for Effective Third-Party Risk Solutions

Updated Category News Views 359

Atlas Systems Achieves Recognition in Gartner's Market Guide Atlas Systems, a prominent leader in third-party risk management solutions, is proud to announce its recognition as a representative vendor in the 2025 Gartner Market Guide for Third-Party Risk Management Technology Solutions. This esteemed recognition highlights the company’s growing influence in transforming...

Continue Reading
Taco Cabana Kicks Off 2025 with Delicious New Menus!

Updated Category News Views 544

Taco Cabana Launches Flavorful New Menu for 2025 The countdown to the new year just became even more appetizing as Taco Cabana is excited to unveil an unforgettable lineup of menu items designed to tantalize taste buds. With offerings that are as bold as they are delicious, Taco Cabana aims to celebrate the new year in style. Beginning January 2, 2025, guests can look...

Continue Reading
Inspecs Group PLC's Recent Trading Activity Overview

Updated Category News Views 239

Essential Insights on Inspecs Group PLC Trading Transactions The financial world is often dynamic and filled with intricate details, especially when it comes to disclosures made by companies. This article focuses on recent dealings related to Inspecs Group PLC and how they fit into the larger context of market activities. Key Information of Recent Dealings As an exempt...

Continue Reading
First Trust Launches ETF to Cater to Clean Energy Demands

Updated Category News Views 165

Introduction to the New ETF from First Trust First Trust Advisors has rolled out the First Trust Indxx Critical Metals ETF (NYSE: FMTL). This marks a significant milestone as it is the 300th ETF from the firm. This innovative fund aims to meet the surging demand from investors for companies focused on the critical metals necessary for clean energy technologies, including...

Continue Reading